Vistagen, a late clinical-stage biopharmaceutical company, announced the appointment of Nick Tressler as Chief Financial Officer (CFO).
Nick Tressler brings over 20 years of financial leadership experience in the life sciences industry.
Mr. Tressler's appointment is a significant strategic move for Vistagen to accelerate into the next phase.
Experience in Life Sciences Industry
Nick Tressler has served as CFO in various biopharmaceutical companies, bringing extensive operational experience.
Educational Background
Mr. Tressler holds an M.B.A. from Johns Hopkins University Carey Business School and a B.S. from the University of Maryland, College Park, Robert H. Smith School of Business.
Incentive Option
The Compensation Committee granted Mr. Tressler an option to purchase up to 150,000 shares of Vistagen's common stock as an inducement to his appointment.
- Mr. Tressler's appointment is expected to enhance Vistagen's financial strategies and long-term value creation.
- His experience and strategic acumen will be instrumental in guiding Vistagen through pivotal growth and transformation.
The appointment of Nick Tressler as CFO marks a pivotal moment in Vistagen's evolution, aligning with major clinical milestones and a mission-driven team dedicated to innovation and patient care.